nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

17.02.2018 | Editorial Commentary

Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma

verfasst von: Nicolas Aide, Charline Lasnon, Gandhi Damaj

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Excerpt

Diffuse large B cell lymphoma (DLBCL) is the most common type of mature B-cell non-Hodgkin lymphoma, accounting for approximately one-third of all cases. This is a heterogeneous disease with different prognostic patterns. Patients benefit from immuno-chemotherapy; however, 30 to 40% of patients are refractory to it or rapidly relapse after first-line treatment, emphasizing the need to better characterize these patients. …

Ziepert M, Hasenclever D, Kuhnt E, Glass B, Schmitz N, Pfreundschuh M, et al. Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28:2373–80. https://doi.org/10.1200/jco.2009.26.2493.CrossRefPubMed

Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494–502. https://doi.org/10.1158/1078-0432.ccr-09-0113.CrossRefPubMed

Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100:9991–6. https://doi.org/10.1073/pnas.1732008100.CrossRefPubMedPubMedCentral

Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 2014;123:1214–7. https://doi.org/10.1182/blood-2013-11-536433.CrossRefPubMedPubMedCentral

Mareschal S, Ruminy P, Bagacean C, Marchand V, Cornic M, Jais JP, et al. Accurate classification of germinal Center B-cell-like/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: a CALYM study. J Mo Diagn. 2015; https://doi.org/10.1016/j.jmoldx.2015.01.007.

Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, et al. Report of the 6th international workshop on PET in lymphoma. Leuk Lymphoma. 2017;58:2298–303. https://doi.org/10.1080/10428194.2017.1298752.CrossRefPubMed

Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casasnovas RO, Biggi A, et al. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:2017–22. https://doi.org/10.1007/s00259-014-2822-7.CrossRefPubMed

Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276–81. https://doi.org/10.2967/jnumed.116.180406.CrossRefPubMed

Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17–31. https://doi.org/10.1007/s00259-017-3740-2.CrossRefPubMedPubMedCentral

10.

Lasnon C, Enilorac B, Popotte H, Aide N. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs). EJNMMI Res. 2017;7:30. https://doi.org/10.1186/s13550-017-0279-y.CrossRefPubMedPubMedCentral

11.

Toledano MN, Desbordes P, Banjar A, Gardin I, Vera P, Ruminy P, et al. Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2018; https://doi.org/10.1007/s00259-017-3907-x.

12.

Oliveira FPM, Faria DB, Costa DC, Castelo-Branco M, Tavares JMRS. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images. Eur J Nucl Med Mol Imaging. 2017; https://doi.org/10.1007/s00259-017-3918-7.

13.

Aide N, Talbot M, Fruchart C, Damaj G, Lasnon C. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2017; https://doi.org/10.1007/s00259-017-3899-6.

14.

Lasnon C, Majdoub M, Lavigne B, Do P, Madelaine J, Visvikis D, et al. (18)F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer. Eur J Nucl Med Mol Imaging. 2016;43:2324–35. https://doi.org/10.1007/s00259-016-3441-2.CrossRefPubMed

Titel: Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma
verfasst von: Nicolas Aide
Charline Lasnon
Gandhi Damaj
Publikationsdatum: 17.02.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-3966-7

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis

Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study

Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma

Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy